Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - A prospective audit

BJU International

Volumn 110, Issue 11 B, 2012, Pages

  Ahmad, Sarfraz ^a   Aboumarzouk, Omar ^a   Somani, Bhaskar ^a   Nabi, Ghulam ^a   Kata, Slawomir Grzegorz ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Photodynamic diagnosis; Transitional cell carcinoma; Ureterorenoscopy

Indexed keywords

AMINOLEVULINIC ACID; DIAGNOSTIC AGENT; PHOTOSENSITIZING AGENT;

AGED; BLADDER INJURY; BLUE LIGHT; CLINICAL ARTICLE; CYSTOSCOPE; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY PELVIS; MALE; MEDICAL AUDIT; OPERATION DURATION; PHOTODYNAMICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TRANSITIONAL CELL CARCINOMA; URETER INJURY; URETERORENOSCOPE; URETERORENOSCOPY; URETHRA INJURY; URINARY TRACT BIOPSY; URINARY TRACT CARCINOMA; UROLOGIC EXAMINATION; UROLOGICAL ENDOSCOPE; WHITE LIGHT; WHITE LIGHT ENDOSCOPY; ARTICLE; BIOPSY; BLADDER TUMOR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; METHODOLOGY; ORAL DRUG ADMINISTRATION; REPRODUCIBILITY;

ADMINISTRATION, ORAL; AGED; AMINOLEVULINIC ACID; BIOPSY; CARCINOMA, TRANSITIONAL CELL; CLINICAL AUDIT; CYSTOSCOPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; URINARY BLADDER NEOPLASMS;

MLCS; MLOWN;

EID: 84876432768     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11326.x     Document Type: Review

References (23)

1. Smith AK, Stephenson AJ, Lane BR et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 2011 ; 78 : 82-6
2. Moghissi K, Stringer MR, Dixon K. Fluorescence photodiagnosis in clinical practice. Photodiagnosis Photodyn Ther 2008 5 : 235-7
3. Kelly JF, Snell ME. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 1976 ; 115 : 150-1
4. van der Meijden AP, Sylvester R, Oosterlinck W et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 2005 ; 48 : 363-71
5. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004 ; 171 : 135-8
6. Fradet Y, Grossman HB, Gomella L et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007 ; 178 : 68-73
7. Grossman HB, Gomella L, Fradet Y et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007 ; 178 : 62-7
8. Zaak D, Kriegmair M, Stepp H et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 2001 ; 57 : 690-4
9. Kriegmair M, Baumgartner R, Knuechel R et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994 ; 44 : 836-41
10. Witjes JA, Redorta JP, Jacqmin D et al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010 ; 57 : 607-14
11. Kausch I, Sommerauer M, Montorsi F et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2010 ; 57 : 595-606
12. Mowatt G, N'Dow J, Vale L et al. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care 2011 ; 27 : 3-10
13. Somani BK, Moseley H, Eljamel MS, Nabi G, Kata SG. Photodynamic diagnosis (PDD) for upper urinary tract transitional cell carcinoma (UT-TCC): evolution of a new technique. Photodiagnosis Photodyn Ther 2010 7 : 39-43
14. Iinuma S, Bachor R, Flotte T, Hasan T. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol 1995 ; 153 : 802-6
15. Tawfiek E, Bibbo M, Bagley DH. Ureteroscopic biopsy: technique and specimen preparation. Urology 1997 ; 5 0 : 117-19
16. Grasso M, Fraiman M, Levine M. Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies. Urology 1999 ; 54 : 240-6
17. van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Urology 1995 ; 45 : 581-6
18. Althausen AF, Prout GR, Jr, Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976 ; 116 : 575-80
19. van Rhijn BW, van der Poel HG, Boon ME, Debruyne FM, Schalken JA, Witjes JA. Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt. Urology 2000 ; 55 : 363-7
20. Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 2011 ; 29 : 130-6
21. Cheng L, Cheville JC, Neumann RM, Bostwick DG. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999 ; 23 : 443-7
22. Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997 ; 157 : 33-7
23. Raitanen MP, Leppilahti M, Tuhkanen K, Forssel T, Nylund P, Tammela T. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer. Ann Chir Gynaecol 2001 ; 90 : 261-5